Future opportunities in cancer nanotechnology-NCI strategic workshop report

Cancer Research

Volumn 74, Issue 5, 2014, Pages 1307-1310

  Grodzinski, Piotr ^a   Farrell, Dorothy ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOCARRIER; NANOPARTICLE; SMALL INTERFERING RNA;

CANCER PROGNOSIS; CANCER RESEARCH; CHEMICAL COMPOSITION; CLINICAL RESEARCH; CONFERENCE PAPER; DRUG DESIGN; FUNDING; HUMAN; INTERDISCIPLINARY RESEARCH; NANOCHEMISTRY; NANOMEDICINE; NANOPHARMACEUTICS; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; TRANSLATIONAL RESEARCH; TUMOR MICROENVIRONMENT;

ANIMALS; HUMANS; NANOMEDICINE; NANOTECHNOLOGY; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; UNITED STATES;

EID: 84896528555     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2787     Document Type: Conference Paper

References (10)

1. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC, Targeted polymeric therapeutic nanoparticles: design, development, and clinical translation. Chem Soc Rev 2012;41:2971-3010.
2. Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm 2011;8:2101-41.
3. Sahay G, Querbes W, Alabi C, Eltoukhy A, Langer R, Anderson DG, et al. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol 2013;31:653-8.
4. Steenblock ER, Wrzesinski SH, Flavell RA, Fahmy TM, Antigen presentation on artificial acellular substrates:modular systems for flexible, adaptable immunotherapy. Expert Opin Biol Ther 2009;9:451-64.
5. Hrkach J, Von Hoff D, Mukkaram Ali M, Andrianova E, Auer J, Campbell T, et al. Preclinical development and clinical translation of a PSMA targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med 2012;4:128ra39.
6. von Maltzahn G, Park JH, Lin KY, Ruoslahti E, Sailor MJ, Bhatia SN, et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nature Mater 2011;10:545-52.
7. Shi Q, Qin L, Wei W, Geng F, Hood L, Mischel PS, et al. Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells. Proc Natl Acad Sci U S A 2012;109:419-24.
8. Haun JB, Castro CM, Wang R, Peterson VM, Lee H, Weissleder R, et al. Micro-NMR for rapid molecular analysis of human tumor samples. Sci Transl Med 2011;71:71ra16.
9. Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 2013;73:2412-7.
10. Venditto VJ, Szoka FC Jr, Cancer nanomedicines: so many papers and so few drugs!. Adv Drug Deliv Rev. 2013;65:80-8.